NCT06377124

Brief Summary

Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable lung-cancer

Timeline
2mo left

Started Apr 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Apr 2024Jun 2026

First Submitted

Initial submission to the registry

April 9, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

April 22, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

March 19, 2025

Status Verified

March 1, 2025

Enrollment Period

1.9 years

First QC Date

April 9, 2024

Last Update Submit

March 14, 2025

Conditions

Keywords

Lung Cancer

Outcome Measures

Primary Outcomes (1)

  • Change in health-related quality of life

    Measured by a 30-item European Organization for Research and Treatment of Cancer and Lung Module. All scale scores are linearly converted to a range from 0 to 100. Higher scores indicate better functioning and quality of life.

    Baseline and 8-week follow-up

Secondary Outcomes (25)

  • Change in health-related quality of life

    Baseline and 24-week follow-up

  • Change in patient activation

    Baseline, 8-week and 24-week follow-up

  • Change in general self-efficacy

    Baseline, 8-week and 24-week follow-up

  • Change in acceptance of illness

    Baseline, 8-week and 24-week follow-up

  • Change in physical activity level

    Baseline, 8-week and 24-week follow-up

  • +20 more secondary outcomes

Study Arms (2)

The 3S intervention group

EXPERIMENTAL

Receive information and support on self-management of lung cancer

Behavioral: 3S intervention

The GH information group

PLACEBO COMPARATOR

Receive general health information such as sleep hygiene, environmental hygiene, etc.

Behavioral: GH information

Interventions

3S interventionBEHAVIORAL

The 3S intervention includes information and support related to self-management of lung cancer, including 1. an individual 3S session at baseline, 2. 24-week messaging, telephone coaching and hotline services.

The 3S intervention group
GH informationBEHAVIORAL

The GH information includes information related to general health, including 1. an individual GH session at baseline, 2. 24-week messaging, telephone coaching and hotline services.

The GH information group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or above
  • Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer
  • Ambulatory and capable of all self-care activities (ECOG ≤2)
  • Either undergoing or has finished oncology therapy
  • Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators
  • Can speak and read Chinese
  • Willing to complete the patient-reported outcome questionnaire
  • Has a smartphone with WhatsApp or WeChat

You may not qualify if:

  • Preparing for lung operation
  • Skeletal fragility
  • Serious active infection
  • Inability to walk
  • Previously untreated symptomatic brain metastases
  • Severe respiratory insufficiency
  • Uncontrolled pain
  • Diagnosed psychiatric illness with or without medication
  • Family Caregivers:
  • Aged 18 years or above
  • Family caregivers of recruited patients
  • Unable to speak and read Chinese
  • Unwilling to complete the patient-reported outcome questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Queen Elizabeth Hospital

Hong Kong, Ho ManTin, Hong Kong

RECRUITING

Queen Mary Hospital

Hong Kong, Hong Kong

NOT YET RECRUITING

United Christian Hospital

Hong Kong, Hong Kong

RECRUITING

Related Publications (5)

  • Kondylakis H, Bucur A, Crico C, Dong F, Graf N, Hoffman S, Koumakis L, Manenti A, Marias K, Mazzocco K, Pravettoni G, Renzi C, Schera F, Triberti S, Tsiknakis M, Kiefer S. Patient empowerment for cancer patients through a novel ICT infrastructure. J Biomed Inform. 2020 Jan;101:103342. doi: 10.1016/j.jbi.2019.103342. Epub 2019 Dec 6.

    PMID: 31816400BACKGROUND
  • Saetan P, Chaiviboontham S, Pokpalagon P, Chansriwong P. The Effects of the Respiratory Rehabilitation Program on Perceived Self-Efficacy and Dyspnea in Patients with Lung Cancer. Asian Nurs Res (Korean Soc Nurs Sci). 2020 Dec;14(5):277-285. doi: 10.1016/j.anr.2020.08.010. Epub 2020 Sep 8.

    PMID: 32916339BACKGROUND
  • Zhu X, Han S, Chu H, Wang M, Chen S. Influence of self-management exercise intervention on the cancer related fatigue severity and self-management efficacy of patients with non-small cell lung cancer after operation. J Pak Med Assoc. 2020 Sep;70 [Special Issue](9):88-93.

    PMID: 33177734BACKGROUND
  • Hernandez Silva E, Lawler S, Langbecker D. The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review. J Cancer Surviv. 2019 Feb;13(1):97-107. doi: 10.1007/s11764-018-0730-8. Epub 2019 Jan 11.

    PMID: 30635865BACKGROUND
  • Ji W, Kwon H, Lee S, Kim S, Hong JS, Park YR, Kim HR, Lee JC, Jung EJ, Kim D, Choi CM. Mobile Health Management Platform-Based Pulmonary Rehabilitation for Patients With Non-Small Cell Lung Cancer: Prospective Clinical Trial. JMIR Mhealth Uhealth. 2019 Jun 21;7(6):e12645. doi: 10.2196/12645.

    PMID: 31228180BACKGROUND

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Agnes Yuen Kwan Lai, PhD

    School of Nursing and Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agnes Yuen Kwan Lai, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor was not aware of which groups the patients belonged to.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The 3S intervention includes an individual session, messaging and phone contact related to lung cancer self-management, and hotline services. The general health information includes an individual session, messaging and phone contact related to general health information, and hotline services.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Honorary Assistant Professor

Study Record Dates

First Submitted

April 9, 2024

First Posted

April 22, 2024

Study Start

April 22, 2024

Primary Completion

March 31, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

March 19, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

For those who want the patient data, please contact PI directly by written email.

Locations